The National Pharmaceutical Company (NatPharm) is a parastatal under the Ministry of Health and Child Care (MoHCC) which is involved in procurement, warehousing and distribution of medicinesand medical supplies.
Enterprise Wide Risk Management services
NatPharm wishes to invite reputable consultancy firms registered with the Procurement Regulatory Authority of Zimbabwe (PRAZ) to be considered for the prequalification for provision of consultancy services to institute Enterprise Wide Risk Management (ERM). Once the firms are selected, they will be invited to respond to a request for proposal (RFP) for the required services below:
- ERM Roadmap
- ERM Framework
- Plan of Action and Implementation Monitoring and Review of risks.
- ERM Communication.
- ERM documentation
- Conducting ERM practical riskassessment and risk profiling
NatPharm hereby invites eligible Consulting firms to indicate their interest in providing the services. Consulting firms should provide information demonstrating that they have the required qualifications and relevant experience to perform the Services.
SCOPE
NatPharm seeks to pre-qualify consultancy firms for the Provision of Enterprise Wide Risk Management Consultancy Services.
ASSESSMENT CRITERIA
Assessment will be conducted to enable the client to assess the technical capability of the service providers (Pre-Qualification) as follows;
- Consultancy Firm should be registered with the Procurement Regulatory Authority of Zimbabwe
- A valid A valid Tax Clearance Certificate (ITF263 form)
- Three (3) written traceable references for each proposed key personnel
- Three (3) written traceable references for the Consultancy Firm
- A minimum of Five (5) Years’ Experience or more in provision of Enterprise Wide Risk Management Consultancy Services for the proposed key personnel
- Five (5) Years’ Experience or more in provision of Enterprise Wide Risk Management for the consultancy firm.
Participation in this bidding procedure is restricted to Zimbabwean bidders only. Bidding documents must be accompanied with CR14 certificates as proof of Nationality.
Short-listed Consultants/Firms will be invited to submit detailed technical and financial proposals, as described in Part one of the Request for Proposals Procedures in the Standard Request for Proposals for the Selection of Consultancy Services.
The expression of Interest document is obtained upon request. Request may be sent through email to procurement@natpharm.co.zw
The Expression of Interest shall close on 26th of March 2020 at 1000hours. Expression of Interest (EOI) must be submitted to: The Procurement Management Unit- National Pharmaceutical Company, 14 Lobengula Road, Southerton, Harare.
The Expression of Interest must be enclosed in sealed envelopes clearly marked “Expression of Interest for the provision of Consultancy Services for the development and implementation of Enterprise Wide Risk Management for NatPharm Company.” before 1000hours on the closing date and time. Any expression of interest submitted after the closing date and time whether by hand or by post will be treated as late E01 and therefore will not be accepted.
This is an Expression of Interest ONLY. It does not constitute a request for proposal (RFP) or a promise to issue an RFP in the future. The request for information does not commit NatPharm for provision of the services whatsoever. Only firms that shall meet all requirements set out in this EOI will be pre-qualified and invited to respond to a request for proposal (RFP) for the required services.
